Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, Status and Forecast 2021-2027

Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, Status and Forecast 2021-2027

  • QYResearch
  • April 2021
  • Healthcare
  • 109 pages

Report Description

Global Hospital-Acquired Infection (HAI) Diagnostic Scope and Market Size
Hospital-Acquired Infection (HAI) Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hospital-Acquired Infection (HAI) Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Molecular Diagnostics
Blood Tests
Urinalysis

Segment by Application
Urinary Tract Infections
Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
bioMrieux
Abbott Laboratories
Alere, Inc.
Roche
Siemens Healthcare
Becton Dickenson
Cepheid Inc.
Thermo Fisher Scientific
Seegene, Inc.
Qiagen

Have query on this report?

Make an Enquiry
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Molecular Diagnostics
List of Tables
Table 1. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Molecular Diagnostics
Table 3. Key Players of Blood Tests
Table 4. Key Players of Urinalysis
Table 5. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

Success Stories

Our Clients